[1]
R. Ravasio and S. Ripoli, “Cost-minimization analysis of HYQVIA® in the treatment of primary immunodeficiency disease (PID) and secondary immunodeficiency disease (SID) in Italy”, AboutOpen, vol. 10, no. 1, pp. 69–77, May 2023.